Pfizer testing third dose of coronavirus vaccine to protect against variants

• Pfizer and BioNTech believe their current two-dose vaccine will work against the South African variant as well as one found in the UK and elsewhere
• But the new studies will allow the companies to be prepared if and when more protection is necessary